“I just couldn’t believe it when I was first told. The news is still sinking in and I’m receiving lots of lovely messages from well-wishers.   “None of ...

At a median follow-up of 33.5 months, the overall response rate for patients given Tecartus was 87%. Patients with relapsed/refractory mantle cell lymphoma ...

The patient and family have a choice earlier in their journey as to whether they wish to have a trained companion volunteer sit bedside near end of life. We ...

Open communication between patients and providers is essential in cancer care. In fact, there are three important conversations patients should be having ...

I have been a Reiki practitioner since 1997. At the time, there were probably only 3 or 4 books written on the topic while today there are hundreds of ...

CAR-T cell therapy Breyanzi (lisocabtagene maraleucel) has been found by researchers to be a cost-effective second-line treatment for patients with relapsed ...

The Food and Drug Administration (FDA) approved Udenyca Onbody, an injector for Udenyca (pegfilgrastim-cbqv) that attaches to the patient’s body, according ...

A patient in a phase 2 trial has received the first dose of a novel cancer vaccine in combination with Keytruda (pembrolizumab) as neoadjuvant (treatment ...

Health has always been one of my priorities as a young child. Throughout my life, I have faced many obstacles, however, being diagnosed with colon cancer at ...

The DONNA Foundation today announced its calendar of events for the 2024 DONNA Marathon race weekend. Now in its 17th year providing a vibrant and exciting ...